Guest: Alan M. Ehrlich, MD, FAAFP Music Credit: Richard Onorato
This study looked at hospitalizations following legislation that legalized marijuana use in Colorado compared to two states that have not legalized marijuana, New York and Oklahoma. The goal was to determine what impact this law might have on common and chronic conditions. It found hospitalizations for some conditions increased while issues of social anxiety disorder decreased.
Guest: Alan Ehrlich MD, FAAFPMusic Credit: Richard Onorato
Cannabis use has been increasing as numerous states have decriminalized or even legalized cannabis possession and use. As a result, the rates of pregnant women who use cannabis have been rising. Learn more about these trends and the risks associated with cannabis use in pregnancy.
Marijuana has become the new fashion statement of medicine. An illegal substance that was, in recent decades, described as the gateway drug, has now found a place within the pharmaceutical industry and the doctor’s office. To prescribe or not to prescribe? This lecture will help you answer that question with information on the proposed mechanisms of action, indications for use, and risks of using medical cannabis in pain management. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on February 6, 2020 and they are subject to change as new information is published.
Cannabis use continues to rise in the United States, driven by expansion of laws legalizing recreational and medical use. With this increased use comes an increase in side effects, such as lung injuries from vaping and a rise in cannabis use disorder. We will discuss what practitioners should know about vaping and cannabis use, and what they should tell their patients. This session will also inform the attendees the most recent clinical and radiographic findings in patients diagnosed with e-cigarette and vaping associated acute lung injury.
As cannabis products become increasingly popular and gain legality throughout the United States, it can be confusing to understand the difference between those your patient can purchase at the corner store vs. FDA-approved products. This webcast will explain those distinctions as well as discuss safety concerns with the use of cannabis products. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 11/11/2020 and they are subject to change as new information is published.
Increasingly, patients are approaching their clinicians with questions about cannabis products. This webcast aims to answer these common questions including the difference between cannabis products that are FDA-approved compared to those that are not, and what conditions have evidence and approvals for the use of cannabinoids. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 11/11/2020 and they are subject to change as new information is published.